GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-10-30 21:15 |
GENFIT: Reports Third Quarter 2019 Financial Information
|
English | 189.5 KB | ||
| 2019-10-21 23:15 |
GENFIT : Assemblée générale ordinaire et extraordinaire du 27 novembre 2019 – m…
|
French | 12.4 KB | ||
| 2019-10-21 22:15 |
GENFIT : Assemblée générale ordinaire et extraordinaire du 27 novembre 2019 – m…
|
French | 156.7 KB | ||
| 2019-10-21 22:15 |
GENFIT: Combined Shareholders’ Meeting of November 27, 2019 – Availability of P…
|
English | 236.4 KB | ||
| 2019-10-07 23:15 |
GENFIT: Upcoming Investor Events
|
English | 10.9 KB | ||
| 2019-09-30 23:45 |
Genfit: H1 2019 Results and R&D Pipeline Progression
|
English | 190.1 KB | ||
| 2019-09-26 23:15 |
GENFIT Reinforces Corporate Leadership in the U.S.
|
English | 16.7 KB | ||
| 2019-09-26 22:15 |
GENFIT Reinforces Corporate Leadership in the U.S.
|
English | 259.7 KB | ||
| 2019-09-26 22:15 |
GENFIT renforce son équipe dirigeante aux États-Unis
|
French | 188.8 KB | ||
| 2019-09-09 09:03 |
Genfit: GENFIT: Le Docteur Carol L. Addy nommée au poste de Directrice Médicale
|
French | 23.2 KB | ||
| 2019-09-09 08:03 |
Genfit: GENFIT: Le Docteur Carol L. Addy nommée au poste de Directrice Médicale
|
French | 195.3 KB | ||
| 2019-09-09 08:03 |
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
|
English | 263.9 KB | ||
| 2019-09-02 19:21 |
GENFIT : Au nom du Conseil d’Administration, son Président Jean-François Mouney…
|
French | 21.7 KB | ||
| 2019-09-02 18:21 |
GENFIT: Board of Directors, Represented by Chairman Jean-François Mouney, Appoi…
|
English | 267.2 KB | ||
| 2019-09-02 18:21 |
GENFIT : Au nom du Conseil d’Administration, son Président Jean-François Mouney…
|
French | 199.5 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
